GlassScriptPhysician profile
Christopher T Caldwell
NPI 1871571364
$2,752.52
in general payments reported to CMS, 2019-2025
8 companies · $446 in 2025
The $446 reported for 2025 was more than what 77% of Neuromusculoskeletal Medicine & Omm providers received nationally (typical 2025 total: $119).
See the full distribution for Neuromusculoskeletal Medicine & OMM
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $138 · 2021: $87.00 · 2023: $1,840 · 2024: $135 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,483 · Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,483.02 |
| Food and Beverage | $937.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,335.15 | 2019-2025 | Superion Indirect Decompression System, General - Pain Management, Wavewriter Alpha Prime 16 |
| Saluda Medical Americas, INC. | $187.16 | 2025 | Evoke |
| Nevro Corp. | $58.86 | 2020-2023 | Senza |
| Abbott Laboratories | $54.00 | 2019-2025 | Eterna |
| Heron Therapeutics, INC. | $48.00 | 2019 | |
| Globus Medical, INC. | $33.82 | 2025 | Senza |
| Medtronic, INC. | $20.79 | 2025 | Inceptiv |
| Novo Nordisk INC | $14.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Caldwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.